An elite broadly neutralizing antibody protects SARS-CoV-2 Omicron variant challenge
Biao Zhou(University of Hong Kong), Zhiwei Chen(Fujian Medical University), Chris Chun-Yiu Chan(University of Hong Kong), Mengxiao Luo(University of Hong Kong), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Runhong Zhou(National Institute for Communicable Disease Control and Prevention), Shuofeng Yuan(University of Hong Kong - Shenzhen Hospital), Hin Chu(University of Hong Kong), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Hiu-On Man(University of Hong Kong), Pui Wang(University of Hong Kong), Bobo Wing-Yee Mok(Chinese University of Hong Kong), Ka‐Kit Au(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Honglin Chen(University of Hong Kong), Bo‐Hao Chen(University of Hong Kong), Lu Lu(Fudan University), Qiaoli Peng(Shenzhen Third People’s Hospital), Vincent Kwok‐Man Poon(Queen Mary Hospital), Jessica Oi‐Ling Tsang(University of Hong Kong), Chris Chung‐Sing Chan(University of Hong Kong)
Cited by 6
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k